Loading provider…
Loading provider…
Psychiatry Physician in Morristown, NJ
NPI: 1427037803Primary Employer
Marc Cantillon MD
livingstonpsychiatrist.com
HQ Phone
Get M.D. Marc's Phone Numberphone_androidMobile
Get M.D. Marc's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNJ State Medical License
NY State Medical License
NJ State Medical License
2004 - 2027
NY State Medical License
1994 - 2021
DE State Medical License
2002 - 2020
MD State Medical License
2020
PA State Medical License
2009 - 2020

American Board of Psychiatry and Neurology
Psychiatry
National Institutes of Health Clinical Center
Residency • Psychiatry
1992 - 1995
Icahn School of Medicine at Mount Sinai (Beth Israel)
Residency • Psychiatry
1990 - 1992
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)
Residency • Internal Medicine
1989 - 1989
Karolinska Institute Faculty of Medicine
Medical School
Until 1987
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 90834Psychotherapy, 45 minutes | 120 | 1,242 |
| 2 | 90832Psychotherapy, 30 minutes | 116 | 933 |
| 3 | 90791Psychiatric diagnostic evaluation | 106 | 107 |
| 4 | 90836Psychotherapy with evaluation and management visit, 45 minutes | 104 | 105 |
| 5 | 99213Established patient office or other outpatient visit, typically 15 minutes | 104 | 105 |
Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial.
Authors: Robert Hauser, Marc Cantillon, Emmanuelle Pourcher, Federico Micheli, Vincent Mok, Marco Onofrj, Susan Huyck, Kenneth Wolski
Publication Date: 2011-02-15
Authors: @ValidYN, LastName, ForeName, Initials, AffiliationInfo
Journal: J Neurol Sci
Publication Date: 2024-09-18
A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia.
Authors: Hellerstein, D J, Yanowitch, P, Rosenthal, J, Samstag, L W, Maurer, M, Kasch, K, Burrows, L, Poster, M, Cantillon, M, Winston, A
Journal: Am J Psychiatry
Lead Sponsor: Gazi University
Intervention / Treatment: OTHER: the timed 360° turn test, OTHER: Berg Balance Scale, OTHER: Four Square Step Test, OTHER: Functional Reach Test, OTHER: Trunk Impairment Scale, OTHER: Timed Up and Go Test, OTHER: Hoehn and Yahr Scale, OTHER: Unified Parkinson's Disease Rating Scale
Lead Sponsor: Longevity Biotech
Collaborators: Michael J. Fox Foundation for Parkinson's Research, Corporal Michael J. Crescenz VA Medical Center - Philadelphia
Intervention / Treatment: DIAGNOSTIC_TEST: LBT-3627, DIAGNOSTIC_TEST: Immunological profiling
Lead Sponsor: Nantes University Hospital
Intervention / Treatment: OTHER: biopsies of colon